The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Because of the variable clinical course of multiple myeloma, the identification of prognostic parameters is of clinical interest. Therefore, we analyzed the clinical significance of serum levels of soluble human leukocyte antigen class I molecules (sHLA-I), carboxy-terminal telopeptide of type-I col...
Հիմնական հեղինակներ: | Schütt, P, Rebmann, V, Brandhorst, D, Wiefelspütz, J, Ebeling, P, Opalka, B, Seeber, S, Nowrousian, MR, Moritz, T, Grosse-Wilde, H |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2008
|
Նմանատիպ նյութեր
-
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
: Rebmann, V, և այլն
Հրապարակվել է: (2007) -
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
: Schütt, P, և այլն
Հրապարակվել է: (2005) -
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
: Schütt, P, և այլն
Հրապարակվել է: (2005) -
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
: Schütt, P, և այլն
Հրապարակվել է: (2006) -
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
: Schütt, P, և այլն
Հրապարակվել է: (2005)